|
gptkbp:instance_of
|
gptkb:Person
gptkb:CEO
|
|
gptkbp:advocates_for
|
vaccine education
|
|
gptkbp:affiliation
|
gptkb:University_of_Mainz
|
|
gptkbp:awards
|
gptkb:German_Federal_Cross_of_Merit
|
|
gptkbp:birth_date
|
gptkb:1965
|
|
gptkbp:born
|
gptkb:horse_race
|
|
gptkbp:children
|
gptkb:musical
|
|
gptkbp:collaborated_with
|
gptkb:Pfizer
|
|
gptkbp:collaborations
|
gptkb:Research_Institute
academic institutions
international research teams
|
|
gptkbp:community
|
biomedical researchers
|
|
gptkbp:community_engagement
|
healthcare initiatives
|
|
gptkbp:community_impact
|
vaccine distribution
|
|
gptkbp:contribution
|
gptkb:drug
clinical trials
vaccine efficacy studies
m RNA technology
|
|
gptkbp:education
|
gptkb:Hannover_Medical_School
|
|
gptkbp:field
|
immunology
|
|
gptkbp:field_of_study
|
gptkb:Company
|
|
gptkbp:founded
|
Bio N Tech SE
|
|
gptkbp:founder
|
Bio N Tech
|
|
gptkbp:future_plans
|
global health improvement
|
|
gptkbp:goal
|
disease prevention
cancer treatment advancements
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Uğur Şahin
|
|
gptkbp:impact
|
vaccine development
global health
public health advancements
|
|
gptkbp:influence
|
gptkb:healthcare_organization
|
|
gptkbp:influenced
|
vaccine technology
|
|
gptkbp:influenced_by
|
gptkb:Louis_Pasteur
gptkb:Paul_Ehrlich
|
|
gptkbp:innovation
|
biomedical research
medical science
therapeutic vaccines
new vaccine technologies
|
|
gptkbp:inspired_by
|
gptkb:Albert_Bruce_Sabin
|
|
gptkbp:invention
|
BN T162b2
m RNA vaccine patents
|
|
gptkbp:is_involved_in
|
COVID-19 pandemic response
|
|
gptkbp:known_for
|
co-founding Bio N Tech
m RNA vaccine development
|
|
gptkbp:leadership
|
collaborative
biotech industry
biotechnology sector
Bio N Tech leadership
|
|
gptkbp:moral
|
research integrity
|
|
gptkbp:nationality
|
gptkb:Native_American_tribe
|
|
gptkbp:partnership
|
government agencies
|
|
gptkbp:philanthropy
|
COVID-19 vaccine access initiatives
|
|
gptkbp:position
|
CEO of Bio N Tech
|
|
gptkbp:publishes
|
peer-reviewed journals
|
|
gptkbp:receives_funding_from
|
philanthropic contributions
|
|
gptkbp:recognizes
|
gptkb:Time_100_Most_Influential_People
|
|
gptkbp:research
|
clinical research
data-driven research
|
|
gptkbp:research_areas
|
infectious diseases
|
|
gptkbp:research_focus
|
cancer immunotherapy
infectious disease vaccines
m RNA technology applications
|
|
gptkbp:residence
|
gptkb:Mainz,_Germany
|
|
gptkbp:scientific_classification
|
awards and honors
|
|
gptkbp:scientific_goals
|
improving patient outcomes
|
|
gptkbp:spouse
|
gptkb:Özlem_Türeci
|
|
gptkbp:title_holder
|
Honorary Professor
|
|
gptkbp:vision
|
personalized medicine
transforming healthcare
|
|
gptkbp:works_at
|
Bio N Tech
|
|
gptkbp:bfsParent
|
gptkb:Biontech
|
|
gptkbp:bfsLayer
|
6
|